Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Haematologica|May 5, 2025
<i>Erratum</i> to: Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
European Journal of Haematology|July 10, 2024
CRP and sCD25 help distinguish between adult-onset Still's disease and HLHMadelaine Beckett, Caroline Spaner, Mariam Goubran, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
American Journal of Hematology|September 26, 2025
Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLHSteven Rowe, Mariam Goubran, Mateo Sarmiento Bustamante, et al.
Insights Into Imaging|March 12, 2021
Emerging role of 18F-FDG PET/CT in Castleman disease: a reviewBenjamin Koa, Austin J Borja, Mahmoud Aly, et al.
Journal of Clinical Pathology|February 20, 2024
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related diseaseAsami Nishikori, Midori Filiz Nishimura, David C Fajgenbaum, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2021
Transcriptome and unique cytokine microenvironment of Castleman diseaseAnna Wing, Jason Xu, Wenzhao Meng, et al.
American Journal of Hematology|July 15, 2021
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman diseaseYoshito Nishimura, David C Fajgenbaum, Sheila K Pierson, et al.
The Journal of Experimental Medicine|May 10, 2021
DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cellsJung-Yeon Lim, Sascha H Duttke, Turner S Baker, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Haematologica|May 5, 2025
<i>Erratum</i> to: Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
European Journal of Haematology|July 10, 2024
CRP and sCD25 help distinguish between adult-onset Still's disease and HLHMadelaine Beckett, Caroline Spaner, Mariam Goubran, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
American Journal of Hematology|September 26, 2025
Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLHSteven Rowe, Mariam Goubran, Mateo Sarmiento Bustamante, et al.
Insights Into Imaging|March 12, 2021
Emerging role of 18F-FDG PET/CT in Castleman disease: a reviewBenjamin Koa, Austin J Borja, Mahmoud Aly, et al.
Journal of Clinical Pathology|February 20, 2024
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related diseaseAsami Nishikori, Midori Filiz Nishimura, David C Fajgenbaum, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 23, 2021
Transcriptome and unique cytokine microenvironment of Castleman diseaseAnna Wing, Jason Xu, Wenzhao Meng, et al.
American Journal of Hematology|July 15, 2021
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman diseaseYoshito Nishimura, David C Fajgenbaum, Sheila K Pierson, et al.
The Journal of Experimental Medicine|May 10, 2021
DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cellsJung-Yeon Lim, Sascha H Duttke, Turner S Baker, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Pageof 12